News brief.
The quality and quantity of drug safety reporting is largely insufficient, according to a recent study supported by the Agency for Healthcare Research and Quality and published in the January 24/31 Journal of the American Medical Association. The survey looked at nearly 200 drug trials and found that the severity of side effects was satisfactorily explained in less than half of them.
Jeanne Sabatie. Drug safety story not complete.
Business and Health
2001;3:10.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen